Different Lengths of Gestational Exposure to Secondhand Smoke or e-Cigarette Vapor Induce the Development of Placental Disease Symptoms
Cells · 2024
DOI: 10.3390/cells13121009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Madison N Kirkham und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lung and Placenta Laboratory, Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USA. Hauptthemen laut MEDLINE: Tobacco Smoke Pollution, Mice, Inbred C57BL, Placenta. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NHLBI NIH HHS, National Institute of health.
Abstract (Originalsprache)
Exposure to cigarette smoke is known to induce disease during pregnancy. Recent evidence showed that exposure to secondhand smoke (SHS) negatively impacts fetal and placental weights, leading to the development of intrauterine growth restriction (IUGR). Electronic cigarettes (eCigs) represent a phenomenon that has recently emerged, and their use is also steadily rising. Even so, the effects of SHS or eCigs during gestation remain limited. In the present study, we wanted to characterize the effects of SHS or eCig exposure at two different important gestational points during mouse pregnancy. C57/Bl6 mice were exposed to SHS or eCigs via a nose-only delivery system for 4 days (from 14.5 to 17.5 gestational days (dGA) or for 6 days (from 12.5 dGA to 17.5 dGA)). At the time of necropsy (18.5 dGA), placental and fetal weights were recorded, maternal blood pressure was determined, and a dipstick test to measure proteinuria was performed. Placental tissues were collected, and inflammatory molecules in the placenta were identified. Treatment with SHS showed the following: (1) a significant decrease in placental and fetal weights following four days of exposure, (2) higher systolic and diastolic blood pressure following six days of exposure, and (3) increased proteinuria after six days of exposure. Treatment with eCigs showed the following: (1) a significant decrease in placental weight and fetal weight following four or six days of exposure, (2) higher systolic and diastolic blood pressure following six days of exposure, and (3) increased proteinuria after six days of exposure. We also observed different inflammatory markers associated with the development of IUGR or PE. We conclude that the detrimental effects of SHS or eCig treatment coincide with the length of maternal exposure. These results could be beneficial in understanding the long-term effects of SHS or eCig exposure in the development of placental diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lung and Placenta Laboratory, Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USA.
- Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA.
ORCID-Profile: Brett E Pickett, Paul R Reynolds, Juan A Arroyo
Förderung
- NICHD NIH HHS
- NHLBI NIH HHS
- National Institute of health
- National Institutes of Health
Zitieren
APA
Kirkham, M. N., Cooper, C., Broberg, E., Robertson, P., Clarke, D., Pickett, B. E., Bikman, B., Reynolds, P. R., & Arroyo, J. A. (2024). Different Lengths of Gestational Exposure to Secondhand Smoke or e-Cigarette Vapor Induce the Development of Placental Disease Symptoms. Cells. https://doi.org/10.3390/cells13121009
Vancouver
Kirkham MN, Cooper C, Broberg E, Robertson P, Clarke D, Pickett BE, et al. Different Lengths of Gestational Exposure to Secondhand Smoke or e-Cigarette Vapor Induce the Development of Placental Disease Symptoms. Cells. 2024. doi:10.3390/cells13121009
BibTeX
@article{Kirkham2024,
author = {Kirkham, Madison N and Cooper, Christian and Broberg, Emily and Robertson, Peter and Clarke, Derek and Pickett, Brett E and Bikman, Benjamin and Reynolds, Paul R and Arroyo, Juan A},
title = {Different Lengths of Gestational Exposure to Secondhand Smoke or e-Cigarette Vapor Induce the Development of Placental Disease Symptoms},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13121009}
}
EUVIMED